The Global Health European and Developing Countries Clinical Trials Partnership 3 Joint Undertaking (GH EDCTP3 JU) has published a document with the FAQs on their 2023 Work Programme and calls.
The document provides valuable clarifications for applicants regarding the specificities of the GH EDCTP3 eligibility conditions, including variations from the general Horizon Europe rules. The following Q&A on the UK participation in the 2023 calls is also included.
“Can UK legal entities be eligible for funding under Global Health EDCTP3? Can a UK-based entity be the coordinator of a Global Health EDCTP3 project?
The EU and the UK have been discussing the association of the UK to the Horizon Europe programme. Before an association agreement is concluded, entities based in the UK may be neither beneficiaries nor coordinator of a Global Health EDCTP3 project as they are not eligible for funding.
However, until the moment of grant signature consortia may apply and include UK-based entities as beneficiaries and also coordinators. UK-based entities would be treated as potential beneficiaries during the process of proposals’ eligibility and admissibility checks, and evaluation.
In case the UK is not associated at a mature stage of the grant agreement preparation, the status of the UK entities as beneficiaries will be revised; they may still participate in projects as associated partners (not eligible for funding). Where relevant, the consortium may have to change its coordinator and add a participant based in the EU or a country associated to Horizon Europe to fulfil consortium composition requirements.
Therefore, the situation of entities established in the UK will be reassessed during grant agreement preparation and at the moment of grant agreement signature.”